WeVote

Bill

Bill

HD 455

An Act relative to pharmacists as healthcare providers

194th Legislature (2025-2026) Introduced by Christine Barber

The bill aims to elevate pharmacists to full healthcare provider status, expanding their clinical role, authority, and reimbursement for expanded services.

0
WeVote Research Nonpartisan
Bill Summary · HD 455

Summary: HD 455 — An Act relative to pharmacists as healthcare providers

Status: Not specified
Introduced: November 29, 2025
Classification: Proposed bill

Note: The text of the bill is not provided here. This summary reflects the likely core elements typically associated with a bill of this title and purpose. For exact language and provisions, consult the official bill text.

Overview and purpose

HD 455 proposes to elevate the status of pharmacists to be recognized as healthcare providers within the state. The underlying objective is to expand pharmacists’ roles in patient care, improve access to certain health services, and support integrated care delivery by leveraging pharmacists’ training and accessibility.

Key provisions (typical elements likely addressed)

  • Expanded scope of practice: Establish or clarify pharmacists’ authority to provide clinical services beyond dispensing medications, such as medication therapy management, chronic disease management, and other pharmacist-led health interventions.
  • Prescriptive or collaborative authority: Potentially authorize pharmacists to initiate or adjust certain medications (e.g., immunizations, specific chronic disease therapies) under defined protocols or collaborative practice agreements with physicians or other prescribers.
  • Immunizations and point-of-care testing: Permit pharmacists to administer vaccines and conduct point-of-care tests as part of routine care, subject to training, certification, and regulatory standards.
  • Reimbursement and compensation: Create or expand reimbursement pathways for pharmacist-provided services from public programs, private insurers, or through state agency funding, with specifications on billing and eligibility.
  • Professional standards and regulation: Define qualifications, continuing education requirements, and oversight by the state Board of Pharmacy or equivalent regulatory body. Establish quality and safety standards for expanded services.
  • Data sharing and collaboration: Encourage or require coordination with other providers and health systems to ensure integrated care, record-keeping, and appropriate referrals.
  • Liability and protections: Include provisions related to professional liability, scope limitations, and patient safety protections specific to the expanded role.

Who would be affected

  • Pharmacists and pharmacies: Expanded roles, workloads, and potential practice settings (retail, hospital, long-term care).
  • Patients and communities: Increased access to clinical services, timely care, and convenience, particularly for routine management and preventive services.
  • Other healthcare providers: Greater collaboration and need for care coordination with physicians, nurse practitioners, physician assistants, and others.
  • Insurers and state programs: Changes to coverage, billing processes, and reimbursement structures for pharmacist-provided services.

Procedural and timeline considerations

  • As introduced in late November 2025, typical next steps would include committee referrals, public hearings, amendments, and potential floor votes in the legislature, followed by enactment and regulatory rulemaking if enacted. Status updates from the sponsoring chamber or committee would provide current progress.

Potential impacts and considerations

  • Positive: Improved access to care, shorter wait times, and potential cost savings through preventive and management services.
  • Challenges: Ensuring consistent scope across settings, addressing reimbursement parity, and maintaining care coordination with other providers.

For readers seeking precise details, the official bill text and fiscal notes should be reviewed once published.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.